ArticleBone marrow transplantation2017

Persistent recipient-derived human adenovirus (HAdV)-specific T cells promote HAdV control after allogeneic hematopoietic stem cell transplantation.

R E Schultze-Florey et al.PubMed ↗Publisher ↗

No numbers read from the abstract.